Stocks and Investing Stocks and Investing
Fri, July 1, 2022
Thu, June 30, 2022

Andrew Fein Initiated (ABOS) at Strong Buy and Held Target at $15 on, Jun 30th, 2022


Published on 2024-10-27 21:43:09 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Initiated "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Jun 30th, 2022.

Andrew has made no other calls on ABOS in the last 4 months.



There is 1 other peer that has a rating on ABOS. Out of the 1 peers that are also analyzing ABOS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $17 on, Tuesday, March 29th, 2022

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com